combining a dna vaccine with pembrolizumab for mcrpc
Published 2 years ago • 61 plays • Length 1:05Download video MP4
Download video MP3
Similar videos
-
1:30
asessing the ptvg-hp plasmid dna vaccine in patients with mcrpc
-
1:32
combining antigen-specific vaccination and targeted radionuclide therapy in a murine prostate model
-
2:10
evaluation of a dna vaccine for prostate cancer
-
0:52
how do cancer vaccines work?
-
2:07
twt-101: cfi-402411 alone or with pembrolizumab in patients with advanced tumors
-
0:56
vaccines are a promising direction for prostate cancer immunotherapy
-
0:54
neon-1 & neon-2: alpn-202 alone or with pembrolizumab in patients with advanced malignancies
-
5:25
developing vaccines as a treatment for prostate cancer
-
1:35
can vaccines and immune checkpoint inhibitors work together to treat prostate cancer?
-
0:50
phase i study of tak-676 pembrolizumab following radiotherapy in late-line nsclc, tnbc and scchn
-
1:21
combining a parp and pd-l1 inhibitor to treat prostate cancer
-
6:03
prostate-specific membrane antigen activated prodrug and imaging agents
-
2:30
combining vegf tkis with immunotherapy for rcc
-
3:53
(19) dr. marks explains how the artemis device works
-
1:12
plasmamatch trial | a new way to take on cancer | stand up to cancer
-
5:32
ctdna abnormalities in prostate cancer: distinctions in aa versus ca patients
-
4:17
dna specimen provenance assay preventing overdiagnosis of prostate cancer
-
2:40
combining agents to improve response rates in genitourinary cancer
-
2:53
shan lu on lifelong mission to develop dna vaccine for hiv